Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot Study

NCT02155439 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-04-26

No results posted yet for this study

Summary

The aim of study is examine the efficacy of intralesional 5-fluorouracil injections in keloid disease treatment.

Conditions

  • Keloidscars

Interventions

DRUG

5-fluorouracil

antimitotic drug

DRUG

Triamcinolone

Sponsors & Collaborators

  • Tampere University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-12-31
Completion
2018-01-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02155439 on ClinicalTrials.gov